Synergy Shield Coronary Stent 2.25 X 8 | REF H7493966608220
Boston Scientific Synergy Shield Coronary Stent, 2.25 mm x 8 mm, REF H7493966608220. Single-unit B2B catalog listing for hospital and cath lab procurement.
The Terumo Ultimaster Nagomi Coronary Stent (REF DE-RS4509ASM) is a sirolimus-eluting coronary stent system in a 4.50 mm x 9 mm configuration, premounted on a rapid exchange (Rx) delivery catheter. It is engineered for percutaneous coronary intervention in larger-caliber coronary vessels, combining a thin-strut cobalt-chromium platform with a bioresorbable abluminal polymer drug carrier intended to support controlled drug release and subsequent polymer-free healing.
Key Features
- Drug: Sirolimus eluted from a bioresorbable PDLLA-PCL abluminal polymer coating
- Stent platform: Cobalt-chromium alloy with thin struts for low crossing profile
- Design: Open-cell hybrid architecture intended to support conformability and side-branch access
- Delivery system: Rapid exchange (monorail) catheter compatible with 0.014" guidewires
- Size: Nominal diameter 4.50 mm, nominal length 9 mm
- Guide catheter compatibility: Not specified in the located sources
- Sterilization: Supplied sterile, single use only
Clinical Applications
- Improving coronary luminal diameter in patients with symptomatic ischemic heart disease due to de novo lesions in native coronary arteries
- Treatment of larger-caliber target vessels where a 4.50 mm nominal diameter device is appropriate
- Use as part of a percutaneous coronary intervention (PCI) strategy in accordance with the manufacturer's Instructions for Use and applicable local clinical guidelines
Product Information
- Brand: Terumo
- Product line: Ultimaster Nagomi
- Category: Coronary Stents (Drug-Eluting)
- REF / UPN: DE-RS4509ASM
- Stent diameter: 4.50 mm
- Stent length: 9 mm
- Configuration: Premounted, rapid exchange delivery system
- Packaging: Single-use sterile unit; refer to manufacturer labeling for shelf life and storage
- Regulatory status: Not specified in the located sources; buyers should confirm market-specific registration before procurement
REF / UPNDE-RS4509ASM
Size9 mm
Terumo Ultimaster NagomiUltimaster Nagomi stentsirolimus eluting stentcoronary stent 4.50 mmcoronary stent 9 mmDE-RS4509ASMdrug eluting stentbioresorbable polymer stentcobalt chromium coronary stentPCI stentrapid exchange stent systemTerumo coronary stentcardiology procurementinterventional cardiology suppliesB2B medical device sourcing
Related Products
Related products from the same category
Synergy Shield Coronary Stent 2.50 X 8 | REF H7493966608250
Boston Scientific Synergy Shield Coronary Stent, 2.50 mm x 8 mm (REF H7493966608250) for B2B medical device procurement.
Synergy Shield Coronary Stent 2.75 X 8 | REF H7493966608270
Boston Scientific Synergy Shield Coronary Stent, 2.75 mm x 8 mm (REF H7493966608270), available for B2B medical device procurement.
Synergy Shield Coronary Stent 3.00 X 8 | REF H7493966608300
Boston Scientific Synergy Shield Coronary Stent (3.00 mm x 8 mm), REF H7493966608300, supplied for B2B procurement.
Synergy Shield Coronary Stent 3.50 X 8 | REF H7493966608350
Boston Scientific Synergy Shield Coronary Stent, 3.50 mm x 8 mm (REF H7493966608350) for B2B medical device procurement.
Synergy Shield Coronary Stent 4.00 X 8 | REF H7493966608400
Boston Scientific Synergy Shield Coronary Stent, 4.00 mm x 8 mm (REF H7493966608400) for B2B medical device procurement.
Synergy Shield Coronary Stent 2.25 X 12 | REF H7493966612220
Boston Scientific Synergy Shield Coronary Stent, 2.25 mm x 12 mm (REF H7493966612220) for B2B medical device procurement.
Synergy Shield Coronary Stent 2.50 X 12 | REF H7493966612250
Boston Scientific Synergy Shield Coronary Stent, 2.50 mm x 12 mm (REF H7493966612250) for B2B medical device procurement.
Synergy Shield Coronary Stent 2.75 X 12 | REF H7493966612270
Boston Scientific Synergy Shield Coronary Stent, 2.75 mm x 12 mm (REF H7493966612270) for B2B medical device procurement.
Synergy Shield Coronary Stent 3.00 X 12 | REF H7493966612300
Boston Scientific Synergy Shield Coronary Stent, 3.00 mm x 12 mm (REF H7493966612300) for B2B medical device procurement.
Synergy Shield Coronary Stent 3.50 X 12 | REF H7493966612350
Boston Scientific Synergy Shield Coronary Stent, 3.50 mm x 12 mm (REF H7493966612350) for B2B medical device procurement.
Synergy Shield Coronary Stent 4.00 X 12 | REF H7493966612400
Boston Scientific Synergy Shield Coronary Stent, 4.00 mm x 12 mm, REF H7493966612400, supplied for B2B procurement.
Synergy Shield Coronary Stent 4.50 X 12 | REF H7493966612450
Boston Scientific Synergy Shield Coronary Stent, 4.50 mm x 12 mm (REF H7493966612450) for B2B medical device procurement.
Synergy Shield Coronary Stent 5.00 X 12 | REF H7493966612500
Boston Scientific Synergy Shield Coronary Stent, 5.00 mm x 12 mm (REF H7493966612500), supplied for B2B medical device procurement.
Buyer support
Frequently asked questions about Ultimaster Nagomi Coronary Stent 4.50 × 9 mm | REF DE-RS4509ASM
Practical answers for procurement teams reviewing this product page.
Include the exact product family, brand preference, REF/UPN code when available, required quantity, destination country, expected delivery timing and documentation expectations.
Yes. If alternatives are acceptable, mention equivalent brands, compatible models, size ranges and any non-negotiable requirements.
Related products are connected through structured catalog data such as brand, category, product family and country assignment.
No. This page supports sourcing and RFQ organization. Buyers must verify regulatory status, clinical suitability and procurement compliance independently.
Specific codes reduce ambiguity and help supplier teams identify product availability, packaging details and documentation faster.
Yes. The workflow is designed for hospitals, clinics, distributors, wholesalers, importers and procurement departments.
Yes. Products can be connected to multiple countries in the admin panel, and buyers can specify destination details in the RFQ form.
The request is stored with contact and procurement details so the sourcing conversation can be reviewed and followed up clearly.